Bain Capital Life Sciences Investors, LLC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bain Capital Life Sciences Investors, LLC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$6,320,000
-18.3%
2,000,0000.0%0.71%
-11.3%
Q2 2023$7,740,000
+139611.2%
2,000,0000.0%0.80%
+15.2%
Q1 2023$5,540
+53.9%
2,000,0000.0%0.69%
+72.1%
Q4 2022$3,600
-99.9%
2,000,0000.0%0.40%
-20.6%
Q3 2022$4,240,000
-21.2%
2,000,0000.0%0.51%
-19.8%
Q2 2022$5,380,000
-38.0%
2,000,0000.0%0.63%
-25.1%
Q1 2022$8,680,000
-16.2%
2,000,0000.0%0.84%
+2.6%
Q4 2021$10,360,000
-15.6%
2,000,0000.0%0.82%
+7.9%
Q3 2021$12,280,000
-39.2%
2,000,0000.0%0.76%
-42.4%
Q2 2021$20,200,0002,000,0001.32%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders